V. Valentin
4 Papers
V. Valentin is an academic researcher. The author has contributed to research in topics: Internal medicine & Clinical endpoint. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial
Julie Mankikian,Agnès Caille,Martine Reynaud-Gaubert,Marie Agier,J. Bermudez,Philippe Bonniaud,Raphael Borie,Pierre-Yves Brillet,Jacques Cadranel,Isabelle Court-Fortune,Bruno Crestani,Marie-Pierre Debray,Emmanuel Gomez,Anne Gondouin,Sandrine Hirschi-Santelmo,Dominique Israel-Biet,Stéphane Jouneau,Karine Juvin,Julie Léger,Mallorie Kerjouan,Charles-Hugo Marquette,Jean-Marc Naccache,Hilario Nunes,Laurent Plantier,Grégoire Prévot,Sébastien Quétant,Julie Traclet,V. Valentin,Yurdagul Uzunhan,Lidwine Wemeau-Stervinou,Theodora Bejan-Angoulvant,Vincent Cottin,Sylvain Marchand-Adam +32 more
TL;DR: In this article , a randomized, double-blind, two-parallel group, placebo-controlled trial (NCT02990286) was conducted where patients with connective tissue disease-associated ILD or idiopathic interstitial pneumonia (with or without autoimmune features) and a NSIP pattern were randomly assigned in a 1:1 ratio to receive rituximab (1000 mg) or placebo on day 1 and day 15 in addition to mycophenolate mofetil (2 g daily) for 6 months.
50
Changes in the physical and affective dimensions of dyspnoea after a home-based pulmonary rehabilitation in fibrotic idiopathic interstitial pneumonias
Cécile Chenivesse,Sarah Gephine,Martin Dornbierer,V. Valentin,O. Le Rouzic,Lidwine Wemeau,Jean-Marie Grosbois +6 more
TL;DR: An individualised home-based PR programme resulted in short-, medium- and long-term improvements in both physical and affective components of dyspnoea assessed by the D-12 questionnaire.
4
Frequency and characteristics of refractory dyspnea in idiopathic fibrosing interstitial pneumonia.
Nathalie Bautin,Juliette Ferlin,Gaelle Tercé,Camille Ternynck,V. Valentin,Lidwine Wemeau,Cécile Chenivesse +6 more
TL;DR: A significant frequency of refractory dyspnea in patients with f-IIPs and an association with air hunger but no impact on the affective dimension of dyspnea, anxiety, depression and QoL is indicated, suggesting that the mMRC score might not accurately identify patients distressed by their breathlessness.
Rituximab and mycophenolate mofetil in interstitial lung disease (EVER-ILD): one-year follow up results of a randomized controlled trial.
Laurène Mansy,Agnès Caille,M. Reynaud-Gaubert,J. Bermudez,Philippe Bonniaud,Raphaël Borie,Pierre-Yves Brillet,J. Cadranel,Isabelle Court-Fortune,B. Crestani,Marie-Pierre Debray,Mathilde Duprez,Anne Guillaumot,Sandrine Hirschi-Santelmo,D. Israel-Biet,S. Jouneau,Karine Juvin,Mallorie Kerjouan,Julie Mankikian,C. Marquette,Jean-Marc Naccache,Hilario Nunes,L. Plantier,Grégoire Prévot,S. Quetant,Julie Traclet,V. Valentin,Y. Uzunhan,Lidwine Wemeau-Stervinou,Vincent Cottin,Sylvain Marchand-Adam +30 more